DrugPatentWatch Database Preview
Ani Pharms Inc Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for ANI PHARMS INC, and when can generic versions of ANI PHARMS INC drugs launch?
ANI PHARMS INC has two hundred and nineteen approved drugs.
There is one US patent protecting ANI PHARMS INC drugs.
There are fourteen patent family members on ANI PHARMS INC drugs in eleven countries and seventy-two supplementary protection certificates in eleven countries.
Summary for Ani Pharms Inc
| International Patents: | 14 |
| US Patents: | 1 |
| Tradenames: | 120 |
| Ingredients: | 116 |
| NDAs: | 219 |
Drugs and US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | FELBAMATE | felbamate | TABLET;ORAL | 202284-002 | Nov 4, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ani Pharms Inc | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | CAPSULE;ORAL | 074540-001 | Oct 28, 1996 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ani Pharms Inc | TOLMETIN SODIUM | tolmetin sodium | TABLET;ORAL | 073527-001 | Jun 30, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ani Pharms Inc | PINDOLOL | pindolol | TABLET;ORAL | 073609-002 | Mar 29, 1993 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ani Pharms Inc | GUANABENZ ACETATE | guanabenz acetate | TABLET;ORAL | 074267-002 | Jun 1, 1994 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ani Pharms Inc | LANSOPRAZOLE | lansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 078730-001 | Oct 15, 2010 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | CASODEX | bicalutamide | TABLET;ORAL | 020498-001 | Oct 4, 1995 | 5,712,251 | Start Trial |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 5,196,444*PED | Start Trial |
| Ani Pharms Inc | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | 3,937,838 | Start Trial |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | 5,196,444*PED | Start Trial |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | 5,705,517*PED | Start Trial |
| Ani Pharms Inc | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-004 | Mar 18, 1987 | 4,138,475 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ANI PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
| ➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
International Patents for Ani Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 442134 | Start Trial |
| Norway | 335070 | Start Trial |
| World Intellectual Property Organization (WIPO) | 03028708 | Start Trial |
| Spain | 2333306 | Start Trial |
| European Patent Office | 1432411 | Start Trial |
| Mexico | PA04003234 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0296749 | 97C0023 | France | Start Trial | PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D UN SEL D ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; NAT REG. NO/DATE: NL 21126 19961227; FIRST REG.: 12619/0106 19950811 |
| 0463756 | 300048 | Netherlands | Start Trial | PRODUCT NAME: ZOLMITRIPTANUM, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT OF VAN EEN SOLVAAT; NATL. REGISTRATION: RVG 21079 RVG 21080 19970925; FIRST REGISTRATION: PL 12619/0116 19970307 |
| 0281459 | C990002 | Netherlands | Start Trial | PRODUCT NAME: CLOPIDOGREL WATERSTOFSULFAAT; REGISTRATION NO/DATE: EU 1/98/069/001 - EU 1/98/069/003 19980715 |
| 1429780 | 13C0012 | France | Start Trial | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
| 1539166 | 92323 | Luxembourg | Start Trial | PRODUCT NAME: LA COMBINAISON DE (A) DEXTROMETHORPHAN OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, PRECURSEURS OU DERIVES , PAR EX. HYDROBROMURE DE DEXTROMETHORPHAN ET EN PARTICULIER HYDROBROMURE DE DEXTROMETHORPHAN MONOHYDRATE; ET(B) QUINIDINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES , PRECURSEURS OU DERIVES, PAR EX. SULFATE DE QUINIDINE ET EN PARTICULIER SULFATE DE QUINIDINE DEHYDRATE; FIRST REGISTRATION: 20130624 |
| 1718641 | 2012/008 | Ireland | Start Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
